Clinical Trials Browser

Phase 2 × INDUSTRY × Perivascular Epithelioid Cell Neoplasms × Clear all

NCT02494570 2023-04-07

AMPECT

Phase 2 Completed

34 enrolled 15 charts 1 FDA

Perivascular Epithelioid Cell Neoplasms

NCT01690871 2013-08-02

A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa

Phase 2 Withdrawn

Tuberous Sclerosis, Angiomyolipoma, Perivascular Epithelioid Cell Neoplasms